Testing the Cog-Fun Aging Program for Older Adults With Subjective Cognitive Decline
The goal of this clinical trial is to learn if the Cog-Fun Aging program helps older adults with Subjective Cognitive Decline (SCD) manage memory challenges and improve their daily lives. The main questions it aims to answer are: * Does the program help participants better understand their cognitive challenges in daily
| Condition(s) | Subjective Cognitive Decline (SCD), Subjective Cognitive Impairment, Subjective Memory Complaints |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this clinical trial is to learn if the Cog-Fun Aging program helps older adults with Subjective Cognitive Decline (SCD) manage memory challenges and improve their daily lives. The main questions it aims to answer are: * Does the program help participants better understand their cognitive challenges in daily life? * Do participants report using more effective strategies to manage their memory difficulties? * Does the Cog-Fun Aging program reduce negative emotions and self-perceptions related to SCD? Researchers will compare participants who complete the Cog-Fun Aging program with those who do not to determine the program's effectiveness. Participants will: Take part in a 10-week program with weekly sessions. Learn about SCD and how it affects daily life. Practice and monitor str |
| Who can participate | Inclusion Criteria: * experiencing memory changes and feeling concerned about them * a score of 23 or higher on the MoCA (Montreal Cognitive Assessment) * ability to speak and understand Hebrew sufficiently to participate in a Hebrew-speaking group Exclusion Criteria: * a self-reported health condition that significantly impacts functioning (e.g., uncontrolled diabetes, severe heart/lung disease) * residing in a medical institution or nursing home * currently participating in another SCD treatment |
| Ages | 60 Years |
| Sex | All |
| Lead sponsor | Hebrew University of Jerusalem |
| Locations | Jerusalem, Israel; Misgav Regional Council, Israel; Sde Warburg, Israel |
| Start date | 2024-11-20 |
| NCT ID | NCT06816797 |
| Official listing | https://clinicaltrials.gov/study/NCT06816797 |